Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex
Clinical trial NCT03363763 · TERMINATED
Trial details
- NCT number
- NCT03363763
- Sponsor
- Aucta Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-12
- Primary completion
- 2023-03-24
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.